AVITA Medical (RCEL) Receivables - Other (2020 - 2024)
AVITA Medical (RCEL) has disclosed Receivables - Other for 3 consecutive years, with $94000.0 as the latest value for Q2 2024.
- For the quarter ending Q2 2024, Receivables - Other fell 78.73% year-over-year to $94000.0, compared with a TTM value of $94000.0 through Jun 2024, down 78.73%, and an annual FY2022 reading of $898000.0, changed N/A over the prior year.
- Receivables - Other was $94000.0 for Q2 2024 at AVITA Medical, up from $28000.0 in the prior quarter.
- Across five years, Receivables - Other topped out at $682000.0 in Q1 2022 and bottomed at $28000.0 in Q1 2024.
- Average Receivables - Other over 3 years is $255200.0, with a median of $94000.0 recorded in 2024.
- Peak annual rise in Receivables - Other hit 78.73% in 2024, while the deepest fall reached 78.73% in 2024.
- Year by year, Receivables - Other stood at $682000.0 in 2022, then plummeted by 95.6% to $30000.0 in 2023, then soared by 213.33% to $94000.0 in 2024.
- Business Quant data shows Receivables - Other for RCEL at $94000.0 in Q2 2024, $28000.0 in Q1 2024, and $30000.0 in Q4 2023.